Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

DBV Technologies (DBVT) Debt Ratio (2014 - 2020)

DBV Technologies (DBVT) reported Debt Ratio of 0.0 for Q2 2020, down 47.95% year-over-year from 0.01 in Q3 2019, and down 18.3% on a QoQ basis from 0.01 in Q4 2019.

DBV Technologies (DBVT) has 7 years of Debt Ratio data on file, last reported at 0.0 in Q2 2020.

  • Quarterly Debt Ratio fell 47.95% year-over-year to 0.0 in Q2 2020, while the trailing twelve-month figure through Jun 2020 was 0.0 (down 47.95% YoY) and the FY2019 annual result came in at 0.01, down 63.37% from the prior year.
  • Debt Ratio declined to 0.0 in Q2 2020 per DBVT's latest filing, from 0.01 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.02 in Q4 2017 and bottomed at 0.0 in Q2 2020.
  • The 5-year median for Debt Ratio is 0.01 (2018), against an average of 0.01.
  • The widest annual swing landed in 2016, when Debt Ratio tumbled 64.1%; it then jumped 44.62% in 2017.
  • Tracing DBVT's Debt Ratio over 5 years: stood at 0.02 in 2016, then jumped by 44.62% to 0.02 in 2017, then tumbled by 38.16% to 0.01 in 2018, then sank by 62.76% to 0.01 in 2019, then dropped by 18.3% to 0.0 in 2020.
  • Per Business Quant, the three latest DBVT Debt Ratio figures stand at 0.0 (Q2 2020), 0.01 (Q4 2019), and 0.01 (Q3 2019).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 0.18
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 1.41
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 0.05
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -
10 DBV Technologies 8.00 Bn 7.77 Bn -3.90 Mn -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2020 0.00
Dec 31, 2019 0.01
Sep 30, 2019 0.01
Jun 30, 2019 0.01
Dec 31, 2018 0.01
Jun 30, 2018 0.01
Dec 31, 2017 0.02
Jun 30, 2017 0.02
Dec 31, 2016 0.02
Jun 30, 2016 0.01
Dec 31, 2015 0.01
Jun 30, 2015 0.04
Dec 31, 2014 0.03